Evidence map›Paper›PMID 29078331›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.

Robert J Andrew, Celia G Fernandez, Molly Stanley, Hong Jiang, Phuong Nguyen, Richard C Rice, Virginie Buggia-Prévot, Pierre De Rossi, Kulandaivelu S Vetrivel, Raza Lamb and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Biochemistry · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Amyloid Precursor Protein and Alzheimer's Disease.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Robert J AndrewDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Celia G FernandezDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Molly StanleyHope Center for Neurological Disorders, Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Hong JiangHope Center for Neurological Disorders, Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Phuong NguyenDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093.
Richard C RiceDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Virginie Buggia-PrévotDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Pierre De RossiDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Kulandaivelu S VetrivelDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Raza LambDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Arnau ArgemiDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Emilie S AllaertDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Elle M RathbunDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Sofia V KrauseDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
Steven L WagnerDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093.
Angèle T ParentDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637.
David M HoltzmanHope Center for Neurological Disorders, Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Gopal ThinakaranDepartment of Neurobiology, The University of Chicago, Chicago, IL 60637; gopal@uchicago.edu.ORCID 0000-0001-5523-6780
University of Chicago · USHope Center for Neurological Disorders · USUniversity of California San Diego · US

Funding

IMAGING COREP01NS080675 · NINDS · WASHINGTON UNIVERSITY · PI RAICHLE, MARCUS E · 2013 to 2017
$6.2M
STRUCTURAL AND FUNCTIONAL ANALYSIS OF PRESENILINSR01AG019070 · NIA · UNIVERSITY OF CHICAGO · PI THINAKARAN, GOPAL · 2001 to 2015
$4.9M
TRAINING IN NEURAL SYSTEMST32GM007839 · NIGMS · UNIVERSITY OF CHICAGO · PI MASON, PEGGY · 1985 to 2012
$4.2M
Presenilins and Cell Adhesion MoleculesR01NS055223 · NINDS · UNIVERSITY OF CHICAGO · PI PARENT, ANGELE · 2008 to 2012
$1.7M
Multi-purpose Superresolution Microscope for Core FacilityS10OD010649 · OD · UNIVERSITY OF CHICAGO · PI THINAKARAN, GOPAL · 2012 to 2012
$511k
Regulation of BACE1 transcytosis in hippocampal neuronsR21AG051230 · NIA · UNIVERSITY OF CHICAGO · PI THINAKARAN, GOPAL · 2015 to 2016
$435k
Axodendritic signaling of APP-CTFR21AG046710 · NIA · UNIVERSITY OF CHICAGO · PI PARENT, ANGELE · 2014 to 2015
$427k
NIA NIH HHS R01 AG019070NIA NIH HHS R21 AG046710NIA NIH HHS R21 AG051230NIGMS NIH HHS T32 GM007839NIH HHS S10 OD010649NINDS NIH HHS P01 NS080675NINDS NIH HHS R01 NS055223
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by pathological brain lesions and a decline in cognitive function. β-Amyloid peptides (Aβ), derived from proteolytic processing of amyloid precursor protein (APP), play a central role in AD pathogenesis. β-Site APP cleaving enzyme 1 (BACE1), the transmembrane aspartyl protease which initiates Aβ production, is axonally transported in neurons and accumulates in dystrophic neurites near cerebral amyloid deposits in AD. BACE1 is modified by S-palmitoylation at four juxtamembrane cysteine residues. S-palmitoylation is a dynamic posttranslational modification that is important for trafficking and function of several synaptic proteins. Here, we investigated the in vivo significance of BACE1 S-palmitoylation through the analysis of knock-in mice with cysteine-to-alanine substitution at the palmitoylated residues (4CA mice). BACE1 expression, as well as processing of APP and other neuronal substrates, was unaltered in 4CA mice despite the lack of BACE1 S-palmitoylation and reduced lipid raft association. Whereas steady-state Aβ levels were similar, synaptic activity-induced endogenous Aβ production was not observed in 4CA mice. Furthermore, we report a significant reduction of cerebral amyloid burden and BACE1 accumulation in dystrophic neurites in the absence of BACE1 S-palmitoylation in mouse models of AD amyloidosis. Studies in cultured neurons suggest that S-palmitoylation is required for dendritic spine localization and axonal targeting of BACE1. Finally, the lack of BACE1 S-palmitoylation mitigates cognitive deficits in 5XFAD mice. Using transgenic mouse models, these results demonstrate that intrinsic posttranslational S-palmitoylation of BACE1 has a significant impact on amyloid pathogenesis and the consequent cognitive decline.

Indexed as

Alzheimer DiseaseAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloidogenic ProteinsAmyloidosisAmyloid Precursor Protein SecretasesAnimalsAspartic Acid EndopeptidasesAxonsBrainDisease Models, AnimalFemaleLipoylationMaleMemory DisordersAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloidogenic ProteinsAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBace1 protein, mouse5XFADaxonal transportdystrophic neuriteneurodegenerationPDAPP

Identifiers

PMID29078331
PMCPMC5692556
OpenAlexW2765623109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.